Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
HDA Statement on “Most-Favored-Nation” Executive Order
HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.
Faces of the Supply Chain: Distribution Sector Career Pathways
As some of the best minds in distribution convened for the 2024 Distribution Management Conference, HDA spoke with professionals at all stages of their careers to explore paths that led to them to rewarding work. Their insights are featured in the latest installment of the Faces of the Supply Chain video series. In part two of our two-part series, we share some of the valuable perspectives on careers in distribution highlighted during these conversations.
The Rx for Drug Shortages? A Better Understanding of the Supply Chain and Collaborative Solutions
As patients face challenges related to drug shortages, policymakers, regulators and healthcare supply chain leaders are engaged in ongoing discussions about mitigating threats and impact. In this piece, HDA's President and Chief Executive Officer Chip Davis explores some causes and solutions for drug shortages, and how distributors support a resilient supply chain through collaborative efforts and logistics expertise.
Nicolette A. Louissaint To Join HDA as Senior Vice President, Policy and Strategic Planning
The Healthcare Distribution Alliance (HDA) is pleased to announce that Nicolette A. Louissaint, PhD, MBA, has been named the organization’s Senior Vice President of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s Executive Management Team and report to President and Chief Executive Officer Chester “Chip” Davis, Jr. She will join HDA on January 18, 2022, from her current role serving as Executive Director and President of Healthcare Ready in Washington, D.C.